13G Filing: James E. Flynn and Audentes Therapeutics Inc (BOLD)

Page 18 of 18

Page 18 of 18 – SEC Filing

Exhibit B

Due to the relationships between them, the
reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3)
of the Securities Exchange Act of 1934.

Follow Audentes Therapeutics Inc. (NASDAQ:BOLD)

Page 18 of 18